Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine in Intermittent Allergic Rhinitis
NCT00406783Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of desloratadine in allergic rhinitis (AR), sponsored by Organon & Co.. Started Aug 2006; status: completed.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00406783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406783.